Skip to main content

Pliant Therapeutics, Inc.

PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001746473

No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Pliant Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
125
+17 vs. Q3 2022
Shares held
44.7M
−682.4K (−1.5%) vs. Q3 2022
Total value
$864.1M
−$84.0M (−8.9%) vs. Q3 2022
New holders
37
42 more added
Sold out
20
31 more reduced

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 125 institutions
Q1 2021: 76 institutionsQ2 2021: 81 institutionsQ3 2021: 77 institutionsQ4 2021: 88 institutionsQ1 2022: 92 institutionsQ2 2022: 88 institutionsQ3 2022: 110 institutionsQ4 2022: 125 institutionsQ1 2023: 143 institutionsQ2 2023: 144 institutionsQ3 2023: 136 institutionsQ4 2023: 134 institutionsQ1 2024: 135 institutionsQ2 2024: 144 institutionsQ3 2024: 151 institutionsQ4 2024: 161 institutionsQ1 2025: 141 institutionsQ2 2025: 114 institutionsQ3 2025: 100 institutionsQ4 2025: 98 institutionsQ1 2026: 91 institutionsQ2 2026: 86 institutions
Value heldQ4 2022: $864.1M
Q1 2021: $1.21BQ2 2021: $893.6MQ3 2021: $512.8MQ4 2021: $416.5MQ1 2022: $222.1MQ2 2022: $241.5MQ3 2022: $948.1MQ4 2022: $864.1MQ1 2023: $1.50BQ2 2023: $1.05BQ3 2023: $1.04BQ4 2023: $1.14BQ1 2024: $971.3MQ2 2024: $687.2MQ3 2024: $710.6MQ4 2024: $852.6MQ1 2025: $78.5MQ2 2025: $59.7MQ3 2025: $74.7MQ4 2025: $57.0MQ1 2026: $62.5MQ2 2026: $54.8M
Institutions holding PLRX and their total value by quarter
QuarterHoldersValue
Q2 202686$54.8M
Q1 202691$62.5M
Q4 202598$57.0M
Q3 2025100$74.7M
Q2 2025114$59.7M
Q1 2025141$78.5M
Q4 2024161$852.6M
Q3 2024151$710.6M
Q2 2024144$687.2M
Q1 2024135$971.3M
Q4 2023134$1.14B
Q3 2023136$1.04B
Q2 2023144$1.05B
Q1 2023143$1.50B
Q4 2022125$864.1M
Q3 2022110$948.1M
Q2 202288$241.5M
Q1 202292$222.1M
Q4 202188$416.5M
Q3 202177$512.8M
Q2 202181$893.6M
Q1 202176$1.21B

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Pliant Therapeutics, Inc.; share changes are against Q3 2022.

Institutions holding PLRX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Susquehanna International Group, LLP424,896$8.21M0.02%+362,799+584.2%Added
Lord, Abbett & Co. LLC500,788$9.68M0.03%+1,255+0.3%Added
Granahan Investment Management Inc505,184$9.77M0.30%+124,091+32.6%Added
Bessemer Group Inc554,891$10.7M0.03%−34,375−5.8%Reduced
Harvard Management Co Inc562,379$10.9M1.38%00.0%Unchanged
Cormorant Asset Management, LP782,788$15.1M1.02%00.0%Unchanged
Citadel Advisors LLC991,121$19.2M0.02%+573,233+137.2%Added
First Light Asset Management, LLC1,057,881$20.4M1.90%+92,767+9.6%Added
VR Adviser, LLC1,080,000$20.9M3.52%00.0%Unchanged
Price T Rowe Associates Inc1,205,734$23.3M0.00%−26,110−2.1%Reduced
Great Point Partners LLC1,322,870$25.6M5.29%+281,133+27.0%Added
Franklin Resources Inc1,489,444$28.8M0.01%−2,739−0.2%Reduced
BlackRock Inc.1,495,502$28.9M0.00%+126,382+9.2%Added
Polar Capital Holdings Plc1,633,164$31.6M0.25%+533,164+48.5%Added
Casdin Capital, LLC1,675,000$32.4M2.53%+925,000+123.3%Added
Deep Track Capital, LP1,732,946$33.5M1.46%+333,202+23.8%Added
Jennison Associates LLC1,733,590$33.5M0.03%−7,387−0.4%Reduced
TRV GP III, LLC1,839,160$35.6M27.86%−2,000,000−52.1%Reduced
Vanguard Group Inc1,949,044$37.7M0.00%+349,720+21.9%Added
TRV GP IV, LLC2,132,867$41.2M17.53%00.0%Unchanged
Avidity Partners Management LP2,240,400$43.3M1.01%+259,300+13.1%Added
CHI Advisors LLC3,169,892$61.3M16.32%−239,866−7.0%Reduced
Redmile Group, LLC3,878,599$75.0M3.07%−629,605−14.0%Reduced
FMR LLC4,393,231$84.9M0.01%−1,693,262−27.8%Reduced
IFP Advisors, Inc3––00.0%Unchanged
Invesco Ltd.0$00.00%−272,667−100.0%Sold out
Atika Capital Management LLC0$00.00%−195,000−100.0%Sold out
Walleye Capital LLC0$00.00%−152,741−100.0%Sold out
EAM Investors, LLC0$00.00%−109,220−100.0%Sold out
EAM Global Investors LLC0$00.00%−76,076−100.0%Sold out
HarbourVest Partners LLC0$00.00%−64,826−100.0%Sold out
Ergoteles LLC0$00.00%−29,928−100.0%Sold out
Soleus Capital Management, L.P.0$00.00%−21,200−100.0%Sold out
Standard Life Aberdeen plc0$00.00%−19,724−100.0%Sold out
SEI Investments Co0$00.00%−19,653−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−13,438−100.0%Sold out
Walleye Trading LLC0$00.00%−11,280−100.0%Sold out
HRT Financial LP0$00.00%−11,339−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−10,000−100.0%Sold out
Simplex Trading, LLC0$00.00%−3,461−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−1,988−100.0%Sold out
Global Trust Asset Management, LLC0$00.00%−291−100.0%Sold out
Massmutual Trust Co FSB0$00.00%−90−100.0%Sold out
Allworth Financial LP0$00.00%−39−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−51−100.0%Sold out
FourThought Financial, LLC––––Not filed
American Portfolios Advisors––––Not filed